1. Predictive Role for Serum Aldo-Keto Reductase Family1 Member B10 for Early Detection of Hepatocellular Carcinoma in Egyptian Patients
   Abdel-Naser Abdel-Atty Gadallah et al, 2022, Open Access Macedonian Journal of Medical Sciences CrossRef
2. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
   Ting Wang et al, 2020, Frontiers in Oncology CrossRef
3. Role of Biomarkers in Hepatocellular Carcinoma and Their Disease Progression
   S.S. Haque et al, 2023, Liver Cancer - Genesis, Progression and Metastasis CrossRef
4. A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening
   Min Chen et al, 2022, Frontiers in Genetics CrossRef
5. Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma
   Ziran Wang et al, 2024, Journal of Hepatocellular Carcinoma CrossRef
6. Quantitative proteomics identifies a plasma multi-protein model for detection of hepatocellular carcinoma
   Zhenhua Du et al, 2020, Scientific Reports CrossRef